GlobeNewswire 3/3/2021 Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
GlobeNewswire 2/25/2021 Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 1/12/2021 Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire 1/8/2021 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire 12/23/2020 Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire 12/16/2020 Recro Announces Executive Changes
GlobeNewswire 12/7/2020 Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
TeleTrader 11/25/2020 E. Commission OKs first 80M Moderna vaccine batch
GlobeNewswire 11/23/2020 High-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower®...
GlobeNewswire 11/10/2020 Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal V...
GlobeNewswire 11/1/2020 Ingredion to Acquire 100% Ownership in Joint Venture Accelerating Growth in Plant-Based Proteins
TeleTrader 10/14/2020 EMA: Moderna eligible for Marketing Authorization
GlobeNewswire 9/4/2020 Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
TeleTrader 7/27/2020 Moderna jumps 11% as it starts COVID-19 vaccine trial
TeleTrader 5/24/2020 Ex-FDA head says US ahead of China in vaccine development
GlobeNewswire 5/14/2020 argenx reports first quarter 2020 financial results and provides business update
GlobeNewswire 4/13/2020 Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsi...
GlobeNewswire 3/31/2020 Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and T...
GlobeNewswire 3/30/2020 Cytovance Biologics Promotes Dr. Jesse McCool to Chief Executive Officer
GlobeNewswire 3/12/2020 iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO
GlobeNewswire 2/26/2020 Mesoblast Reports Financial Results and Corporate Highlights for First Half Ended December 31, 2019
GlobeNewswire 2/6/2020 Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic...
GlobeNewswire 2/4/2020 Amarantus Releases Letter to Shareholders
GlobeNewswire 1/30/2020 Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
GlobeNewswire 1/14/2020 Seeq Corporation Expands Series B Funding with $24 Million to Fuel Advanced Analytics Growth Strateg...